Le Lézard
Classified in: Health
Subject: SVY

Tonometer Market Size Worth $483.6 Million by 2026 | CAGR 5.3%: Grand View Research, Inc.


SAN FRANCISCO, Dec. 12, 2019 /PRNewswire/ -- The global tonometer market size is anticipated to reach USD 483.6 million by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 5.3% over the forecast period. Rapidly increasing geriatric population and improving life expectancy are some of the major factors expected to contribute toward market growth. People aged 60 and above have an increased risk of developing glaucoma. As these devices play a significant role in the diagnosis and management of glaucoma, the market is anticipated to witness significant growth over the forecast period.

Grand View Research Logo

Key suggestions from the report:

Read 120 page research report with ToC on "Tonometer Market Size, Share And Trends Analysis Report By Type (Applanation, Rebound, Indentation, Dynamic Contour), By Portability (Desktop, Handheld), By End Use (Hospitals, Ophthalmic Centers), By Region, And Segment Forecasts, 2019 - 2026'' at: https://www.grandviewresearch.com/industry-analysis/tonometer-market

According to the Glaucoma Research Foundation, people with diabetes are twice as likely to develop glaucoma as compared to non-diabetics. Additionally, the International Diabetes Federation reported that around 463 million adults (aged 20-79 years) were living with diabetes in 2019, and the number is expected to reach 700 million by 2045. Increasing prevalence of glaucoma risk factors, such as myopia, hypertension, and diabetes, is expected to drive the demand for advanced tonometers in the long run. These devices significantly reduce the risk of infection, are highly convenient and easy to use, and can be used at home as well once the patients have been trained.   

A large number of government and non-government initiatives, such as eye screening programs, state and national eye check-up camps, and ophthalmic awareness drives, are expected to play a significant role in boosting awareness about advanced tonometers. More than 90.0% cases of glaucoma remain undiagnosed in developing countries such as India. Such initiatives help increase the reach and awareness of glaucoma and its early diagnosis.

Frequent introduction of advanced tonometers is an emerging trend in the market. For instance, Icare ic100 by Icare Finland measures IOP at greater accuracy, eliminating the need for general/topical anesthesia or any air puff pressure. 

Grand View Research has segmented the global tonometer market based on type, portability, end use, and region:

Find more research reports on Medical Devices Industry, by Grand View Research:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

logo- https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

 


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: